6 unknown. 6 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 3 | 3 | Unknown 3 |
Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American | Phase 2 / Phase 3 | Unknown | Hospital Universitário Professor Edgard Santos | 22 | 2023-10-01 | 2023-08-25 |
| Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous | Phase 2 / Phase 3 | Unknown | University of Brasilia | 100 | 2022-06-22 | 2023-09-15 |
| Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients 18-Methoxycoronaridine, Glucantime - Leishmaniasis; American, Cutaneous, Drug Side Effect | Phase 2 | Unknown | Infan Industria Quimica Farmaceutica Nacional | 52 | 2021-05-01 | 2020-03-19 |
| Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis Photodynamic therapy, Cryotherapy - Cutaneous Leishmaniasis | Phase 2 | Unknown | Hadassah Medical Organization | 44 | 2009-09-01 | 2011-08-16 |
| Low Antimonial Dosage in American Mucosal Leishmaniasis Meglumine antimoniate - Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis | Phase 2 / Phase 3 | Unknown | Oswaldo Cruz Foundation | 76 | 2008-10-01 | 2018-07-12 |
| Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia Miltefosine , meglumine antimoniate - Cutaneous Leihmaniasis | Phase 2 | Unknown | Centro de Investigaciones Bioclínicas de la Fundación Fader | 2007-10-02 |
Leishmaniasis, Mucocutaneous (4) · Leishmaniasis (2) · Drug-Related Side Effects and Adverse Reactions (1)
Euglenozoa Infections (6) · Infections (6) · Parasitic Diseases (6) · Protozoan Infections (6) · Skin Diseases (6) · Skin Diseases, Infectious (6) · Skin Diseases, Parasitic (6) · Skin and Connective Tissue Diseases (6) · Vector Borne Diseases (6) · Leishmaniasis (4) · Chemically-Induced Disorders (1)
Meglumine Antimoniate (3) · miltefosine (2) · 18-methoxycoronaridine (1) · Cryotherapy (1) · Pentoxifylline (1) · Photochemotherapy (1) · liposomal amphotericin B (1) · tofacitinib (1)
Centro de Investigaciones Bioclínicas de la Fundación Fader (1) · Hadassah Medical Organization (1) · Hospital Universitário Professor Edgard Santos (1) · Infan Industria Quimica Farmaceutica Nacional (1) · Oswaldo Cruz Foundation (1) · University of Brasilia (1)
Brazil (3) · Bolivia (1) · Israel (1)
Armando O. Schubach, MD, PhD (1) · Claes D Enk, MD, PhD (1) · Jonathan Berman, MD, PhD (1) · Jorge Vargas, MD (1)